Dimitrios Linos1,2,3,4, Spyridon Christodoulou5, Vassiliki Kitsou6, Angeliki Karachaliou6, Spyridon Ntelis6, Athanassios Petralias7. 1. Medical School, National and Kapodistrian University of Athens, Athens, Greece. dlinos@hms.harvard.edu. 2. Department of Surgery, Hygeia Hospital, 7 Fragoklisias str., 15125, Maroussi, Greece. dlinos@hms.harvard.edu. 3. Department of Surgery, Evgenideio Hospital, Athens, Greece. dlinos@hms.harvard.edu. 4. American College of Surgeons, Chicago, USA. dlinos@hms.harvard.edu. 5. Department of Surgery, Hygeia Hospital, 7 Fragoklisias str., 15125, Maroussi, Greece. 6. Medical School, National and Kapodistrian University of Athens, Athens, Greece. 7. Department of Statistics, Athens University of Economics and Business, Athens, Greece.
Abstract
BACKGROUND: Health-related quality of life (HRQoL) after thyroidectomy has been recently reported with conflicting conclusions. In this study, we assess HRQoL and neck scar cosmesis of thyroid patients several years after thyroidectomy for benign and malignant pathology. METHODS: Three hundred and thirty patients who underwent thyroidectomy between 2000 and 2010 answered the SF-36 Health Survey and Patient Scar Assessment Questionnaire (PSAQ) in 2010 and at the end of 2018. Changes in the SF-36 and PSAQ scores were analyzed taking into account various demographic, surgical and medical characteristics of the patients. RESULTS: Patients reported worse SF-36 scores after 8.5 years, in scales of physical functioning (p < 0.001), social role functioning (p = 0.002), bodily pain (p = 0.001) and general health perceptions (p < 0.001). Interestingly enough, there were no significant changes in scales of physical role functioning (p = 0.304), mental health (p = 0.681), emotional role functioning (p = 0.903) and vitality (p = 0.121). Multivariate analysis showed that several chronic diseases were related to worse HRQoL scores. On the other hand, PSAQ appearance, symptoms and consciousness scores improved during this period (p < 0.001). CONCLUSIONS: In the long term, patients undergoing thyroidectomy do not show worse HRQoL outcomes in terms of mental health, emotional functioning and vitality, whereas scar cosmesis perception is improved. They show deteriorated outcomes in terms of physical, social functioning and bodily pain, which is mainly related to specific chronic diseases that are common to the aging person.
BACKGROUND: Health-related quality of life (HRQoL) after thyroidectomy has been recently reported with conflicting conclusions. In this study, we assess HRQoL and neck scar cosmesis of thyroid patients several years after thyroidectomy for benign and malignant pathology. METHODS: Three hundred and thirty patients who underwent thyroidectomy between 2000 and 2010 answered the SF-36 Health Survey and Patient Scar Assessment Questionnaire (PSAQ) in 2010 and at the end of 2018. Changes in the SF-36 and PSAQ scores were analyzed taking into account various demographic, surgical and medical characteristics of the patients. RESULTS:Patients reported worse SF-36 scores after 8.5 years, in scales of physical functioning (p < 0.001), social role functioning (p = 0.002), bodily pain (p = 0.001) and general health perceptions (p < 0.001). Interestingly enough, there were no significant changes in scales of physical role functioning (p = 0.304), mental health (p = 0.681), emotional role functioning (p = 0.903) and vitality (p = 0.121). Multivariate analysis showed that several chronic diseases were related to worse HRQoL scores. On the other hand, PSAQ appearance, symptoms and consciousness scores improved during this period (p < 0.001). CONCLUSIONS: In the long term, patients undergoing thyroidectomy do not show worse HRQoL outcomes in terms of mental health, emotional functioning and vitality, whereas scar cosmesis perception is improved. They show deteriorated outcomes in terms of physical, social functioning and bodily pain, which is mainly related to specific chronic diseases that are common to the aging person.
Authors: Olga Husson; Harm R Haak; Wilma A Oranje; Floortje Mols; Peter H M Reemst; Lonneke V van de Poll-Franse Journal: Clin Endocrinol (Oxf) Date: 2011-10 Impact factor: 3.478
Authors: Briseis Aschebrook-Kilfoy; Benjamin James; Sapna Nagar; Sharone Kaplan; Vanessa Seng; Habibul Ahsan; Peter Angelos; Edwin L Kaplan; Marlon A Guerrero; Jennifer H Kuo; James A Lee; Elliot J Mitmaker; Jacob Moalem; Daniel T Ruan; Wen T Shen; Raymon H Grogan Journal: Thyroid Date: 2015-12-01 Impact factor: 6.568
Authors: M Giusti; F Sibilla; C Cappi; M Dellepiane; F Tombesi; E Ceresola; C Augeri; E Rasore; F Minuto Journal: J Endocrinol Invest Date: 2005 Jul-Aug Impact factor: 4.256
Authors: Richard Crevenna; Georg Zettinig; Mohammad Keilani; Martin Posch; Manuela Schmidinger; Christian Pirich; Martin Nuhr; Michael Wolzt; Michael Quittan; Veronika Fialka-Moser; Robert Dudczak Journal: Support Care Cancer Date: 2003-06-03 Impact factor: 3.603
Authors: Rebecka R Malterling; Roland E Andersson; Sture Falkmer; Ursula Falkmer; Eva Niléhn; Johannes Järhult Journal: Acta Oncol Date: 2010-05 Impact factor: 4.089